Hemophagocytic syndrome after living-related liver transplantation
Articles > Article · 2003
Authors: Abdullah Zeki KARASU, Murat KILIÇ, S. Cagirgan, ELİF LEBE, Funda YILMAZ BARBET, T. Demirbas, YAMAN TOKAT
TRANSPLANTATION PROCEEDINGS, Journal Indexed in SCI Expanded, International, 2003, vol 35, pp 1482-1484
DOI: 10.1016/s0041-1345(03)00511-6
Summary
Hemophagocytic syndrome (HPS) is a life-threatening hematological disorder in immunocompromised patients. Although the number of patients with HPS following liver transplantation is scarce the outcome is usually fatal. We report a patient who developed HPS following living-related liver transplantation (LRLT) and was treated successfully by a combination of intravenous (IV) immunoglobulin (Ig) and granulocyte colony-stimulating factor (GCSF).